Neurocrine Biosciences Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$794,900	$687,500	$572,600	$627,700
Gross Profit	780,900	676,200	563,400	618,400
EBITDA	299,500	152,900	31,300	181,700
EBIT	291,800	145,600	23,700	174,600
Net Income	209,500	107,500	7,900	103,100
Net Change In Cash	794,900	687,500	572,600	627,700
Free Cash Flow	214,300	89,500	54,100	235,200
Cash	340,200	264,000	194,100	233,000
Basic Shares	102,500	101,000	102,500	102,900

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,355,300	$1,887,100	$1,488,700	$1,133,500
Gross Profit	2,321,300	1,847,400	1,465,500	1,119,200
EBITDA	639,700	416,100	264,600	138,100
EBIT	612,600	394,800	249,000	127,200
Net Income	341,300	249,700	154,500	89,600
Net Change In Cash	2,355,300	1,887,100	1,488,700	1,133,500
Cost of Revenue			-72,000	153,700
Free Cash Flow	557,200	361,600	322,900	233,100
Cash	233,000	251,100	262,900	340,800
Basic Shares	103,700	101,000	98,900	97,900